520 Results

People

  1. Postow
    Postow
  2. Motzer
    Motzer
  3. Wolchok
    Wolchok
  4. Hellmann
    Hellmann
  5. Shoushtari
    Shoushtari
  6. Voss
    Voss
  7. Callahan
    Callahan
  8. Abou-Alfa
    Abou-Alfa
  9. Jones
    Jones
  10. Rosenberg
    Rosenberg

Groups

  1. Department of Medicine (394)
  2. Solid Tumor Oncology Division (337)
  3. Hematologic Malignancies, Division of (108)
  4. Melanoma and Immunotherapeutics Service (108)
  5. Genitourinary Oncology Service (101)
  6. Melanoma Disease Management Team (96)
  7. GSK Faculty (83)
  8. Surgery (71)
  9. Gastrointestinal Oncology Service (65)
  10. Weinberg Fellows (61)
  1. "nivolumab"
Formats
  1. Journal Article (342)
  2. Review (93)
  3. Editorial (41)
  4. Meeting Abstract (18)
  5. Correspondence (7)
  6. Guidelines (7)
  7. Research Letter (6)
  8. Book Section (4)
  9. Conference Paper (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (394)
  2. Solid Tumor Oncology Division (337)
  3. Hematologic Malignancies, Division of (108)
  4. Melanoma and Immunotherapeutics Service (108)
  5. Genitourinary Oncology Service (101)
  6. Melanoma Disease Management Team (96)

More Groups

People
  1. Michael Postow (55)
  2. Robert Motzer (50)
  3. Jedd Wolchok (41)
  4. Margaret Callahan (28)
  5. Alexander Shoushtari (27)
  6. Matthew Hellmann (26)

More People

Years
  1. 2025 (35)
  2. 2024 (70)
  3. 2023 (75)
  4. 2022 (52)
  5. 2021 (45)
  6. 2020 (64)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (23)
  2. Journal of Clinical Oncology (22)
  3. Journal of Thoracic Oncology (21)
  4. Lancet Oncology (21)
  5. New England Journal of Medicine (19)
  6. Annals of Oncology (17)

More Publications

Publishers
  1. Elsevier Inc. (77)
  2. Elsevier Science, Inc. (50)
  3. Oxford University Press (35)
  4. Wiley Blackwell (32)
  5. Biomed Central Ltd (27)
  6. Nature Publishing Group (27)

More Publishers

Results (520)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early on-treatment assessment of T cells, cytokines, and tumor DNA with adaptively dosed nivolumab + ipilimumab: Final results from the phase 2 ADAPT-IT study
    Journal Article

    Smithy, J. W.; Kalvin, H. L.; Ehrich, F. D.; Shah, R.; Adamow, M.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Evaluating immune checkpoint blockade in metastatic castration-resistant prostate cancers with deleterious CDK12 alterations in the phase 2 IMPACT trial
    Journal Article

    Nguyen, C. B.; Reimers, M. A.; Perera, C.; Abida, W.; Chou, J.; Feng, F. Y.; Antonarakis, E. S.; McKay, R. R.; Pachynski, R. K.; Zhang, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma
    Journal Article

    Till, J. E.; McDaniel, L.; Chang, C.; Long, Q.; Pfeiffer, S. M.; Lyman, J. P.; PadroĢn, L. J.; Maurer, D. M.; Yu, J. X.; Spencer, C. N.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • A phase 2 study of sitravatinib in combination with nivolumab in patients with advanced or metastatic urothelial carcinoma
    Journal Article

    Msaouel, P.; Sweis, R. F.; Bupathi, M.; Heath, E.; Goodman, O. B. Jr; Hoimes, C. J.; Milowsky, M. I.; Davis, N.; Kalebasty, A. R.; Picus, J.; more...
    European Urology Oncology (2024)

    Fulltext@MSK | Save
  • Diffuse pleural mesotheliomas with genomic near-haploidization: A newly recognized subset with distinct clinical, histologic, and molecular features
    Journal Article

    Yang, S. R.; Jayakumaran, G.; Benhamida, J.; Febres-Aldana, C. A.; Fanaroff, R.; Chang, J.; Gedvilaite, E.; Villafania, L. B.; Sauter, J. L.; Offin, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of immune checkpoint inhibitors in unique cohorts underrepresented in clinical trials
    Journal Article

    Shah, N. J.; Della Pia, A.; Wu, T.; Williams, A.; Weber, M.; Sinclaire, B.; Paleoudis, E. G.; Alaoui, A.; Lev-Ari, S.; Adams, S.; more...
    Cancers (2024)

    Fulltext@MSK | Save
  • Lighting the torch: intratumoural T cell-to-stroma enrichment score as a predictor of immunotherapy response in urothelial carcinoma
    Editorial

    Aggen, D. H.; Rosenberg, J. E.
    Nature Reviews Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Perspectives on geriatric oncology research presented at the 2023 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report
    Editorial

    Abdallah, M.; Akhtar, O. S.; Major, A.; Mian, H.; Tsang, M.; Torka, P.
    Journal of Geriatric Oncology (2024)

    Fulltext@MSK | Save
  • Top advances of the year: Gastroesophageal cancer
    Editorial

    Goodman, K. A.; Hotca, A.; Liu, M.; Strong, V. E.; Ilson, D. H.
    Cancer (2024)

    Fulltext@MSK | Save
  • The emerging role of immunotherapy in resectable non-small cell lung cancer
    Review

    Dunne, E. G.; Fick, C. N.; Isbell, J. M.; Chaft, J. E.; Altorki, N.; Park, B. J.; Spicer, J.; Forde, P. M.; Gomez, D.; Iyengar, P.; more...
    Annals of Thoracic Surgery (2024)

    Fulltext@MSK | Save